x

Search for a diagnostic test

* (*) mandatory field

114 Result(s)

Filter by

Speciality(ies)/objective(s)

Technique(s)

Purpose(s)

Quality management

Country(ies)

Reset
Sort by

Caption : Accreditation =Accreditation ;

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Accreditation Diagnosis of predisposition to breast and ovarian cancer (Panel)
CLCC Institut Paoli Calmettes
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
FRANCE

GRAND-EST
STRASBOURG

Accreditation Diagnosis of predisposition to breast and ovarian cancer (Panel)
CLCC Paul Strauss
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Nordrhein-Westfalen
KÖLN

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
Praxisgemeinschaft für Laboratoriumsmedizin und Humangenetik
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Bayern
MARTINSRIED

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (ATM, BRCA1, BRCA2, CDH1, CHEK2, NBN, PALB2, RAD51C, RAD51D, TP53 genes)
Zentrum für Humangenetik und Laboratoriumsdiagnostik (MVZ)
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Bayern
NEU-ULM

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
genetikum - Zweigniederlassung Neu-Ulm
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Sachsen
DRESDEN

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
Mitteldeutscher Praxisverbund Humangenetik
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Niedersachsen
HANNOVER

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (CHEK2, BRCA1, BRCA2, PALB2, RAD51C genes)
Medizinische Hochschule Hannover
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Bayern
REGENSBURG

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (NGS screening panel: 11 genes)
Universitätsklinikum Regensburg
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Baden-Württemberg
MANNHEIM

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, BRIP1, CHEK2, HOXB13, PALB2, RAD51C, RAD51D, TP53 genes)
Zentrum für Humangenetik Mannheim
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
FRANCE

AUVERGNE-RHONE-ALPES
BRON

Accreditation Diagnosis of prediposition to hereditary breast and ovarian cancer (Panel)
Hospices Civils de Lyon - Groupement Hospitalier EST
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, PCR based techniques, MLPA based techniques

More information
GERMANY

Rheinland-Pfalz
INGELHEIM AM RHEIN

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, MRE11A, PALB2, RAD51C)
Bioscientia Institut für Medizinische Diagnostik GmbH
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Bayern
MÜNCHEN

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, PALB2, RAD51C genes)
Zweigniederlassung der SYNLAB MVZ Augsburg GmbH
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Nordrhein-Westfalen
DORTMUND

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CDH1, RAD51C genes)
Medizinisches Versorgungszentrum (MVZ) Dr. Eberhard und Partner
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Niedersachsen
GÖTTINGEN

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (ATM, BRCA1, BRCA2, CDH1, CHEK2, NBN, PALB2, PTEN, RAD51C, RAD51D, TP53 genes)
Institut für Humangenetik der Universität Göttingen
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Mecklenburg-Vorpommern
ROSTOCK

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
Centogene AG
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Baden-Württemberg
ULM

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CDH1, RAD51C, RAD51D genes)
Universitätsklinikum Ulm
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Baden-Württemberg
FREIBURG

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (BARD1, BRCA1, BRCA2, RAD51C genes)
Synlab MVZ Freiburg GmbH
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Sachsen
LEIPZIG

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHK2 genes)
MVZ Labor Dr. Reising-Ackermann und Kollegen
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Mecklenburg-Vorpommern
ROSTOCK

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes: sequencing / MLPA)
Diagenom GmbH
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
FRANCE

HAUTS-DE-FRANCE
LILLE

Accreditation Diagnosis of hereditary breast and ovarian cancer syndrome (Panel)
CLCC Oscar Lambret
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Baden-Württemberg
HEIDELBERG

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (ATM, BRCA1, BRCA2, CDH1, CHEK2, NBN, PALB2, RAD51C, RAD51D, TP53 genes)
Institut für Humangenetik am Universitätsklinikum Heidelberg
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
GERMANY

Rheinland-Pfalz
MAINZ

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
Universitätsmedizin Mainz
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Baden-Württemberg
TÜBINGEN

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (ATM, BRCA1, BRCA2, BRIP1, CDH1, CHEK2, PALB2, PTEN, RAD51C, RAD51D, STK1 genes)
Institut für Medizinische Genetik und angewandte Genomik Tübingen
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Hamburg
HAMBURG

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
MVZ Fenner & Krasemann
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Schleswig-Holstein
LÜBECK

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, PALB2, RAD51C, RAD51D genes)
Universitätsklinikum Schleswig-Holstein - Campus Lübeck
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, PCR based techniques, MLPA based techniques

More information
GERMANY

Niedersachsen
HANNOVER

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
amedes genetics im MVZ wagnerstibbe
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Mecklenburg-Vorpommern
ROSTOCK

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (NGS Screening Panel, 18 genes)
Centogene AG
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Nordrhein-Westfalen
KÖLN

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, PALB2 genes)
laboratoriumsmedizin köln - Dres. med. Wisplinghoff und Kollegen
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Bayern
MÜNCHEN

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, BRIP1, CDH1, RAD51C, PPM1D, TP53 genes: sequencing, MLPA)
Pränatalmedizin München
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
UNITED KINGDOM

Lanarkshire
GLASGOW

Accreditation Molecular diagnosis of Breast Cancer by Sequencing of the entire coding region of gene (s) plus copy number analysis (BRCA1, BRCA2 genes)
Queen Elizabeth University Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region

More information
GERMANY

Mecklenburg-Vorpommern
GREIFSWALD

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, NBN, PALB2, RAD51C, RAD51D, TP53 genes)
Institut für Humangenetik der Universitätsmedizin Greifswald
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
GERMANY

Hamburg
HAMBURG

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, PALB2, RAD51C, RAD51D, TP53 genes)
Labor Lademannbogen
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Schleswig-Holstein
KIEL

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
Universitätsklinikum Schleswig-Holstein - Campus Kiel
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Baden-Württemberg
KARLSRUHE

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
Labor PD Dr. Volkmann und Kollegen
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Thüringen
JENA

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
Institut für Humangenetik am Universitätsklinikum Jena
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Bayern
WÜRZBURG

Accreditation Molecular diagnosis of hereditary breast and ovarian cancer syndrome (BRCA1, BRCA2, CHEK2, RAD51C, TP53 genes)
Universität Würzburg - Biozentrum
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
FRANCE

AUVERGNE-RHONE-ALPES
CLERMONT-FERRAND

Accreditation Diagnosis of susceptibility to tumors (melanoma, pancreas, kidney, breast-ovary, colon, skin cancer) (Panel)
CLCC Jean Perrin
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, PCR based techniques, MLPA based techniques

More information
FRANCE

ILE-DE-FRANCE
PARIS

Accreditation Diagnosis of hereditary breast and ovarian cancer syndrome (Panel)
CLCC Institut Curie
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
FRANCE

ILE-DE-FRANCE
PARIS

Accreditation Diagnosis of predisposition to breast and ovarian cancer syndrome (Panel)
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Purpose(s) : Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Nordrhein-Westfalen
AACHEN

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
Universitätsklinikum Aachen
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
FRANCE

NORMANDIE
CAEN

Accreditation Diagnosis of hereditary breast and ovarian cancer syndrome (Panel)
Centre François Baclesse
Purpose(s) : Post-natal diagnosis, Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
CANADA

Ontario
MISSISSAUGA

Accreditation Molecular Cytogenetic Solid Tumor Analysis (Paraffin Embedded Tissue ALK, MYC, ERBB2)
Trillium Health Partners- Credit Valley Site
Purpose(s) : Somatic genetics
Specialty(ies) : Cytogenetics
Objective(s) : Detection of chromosome alterations large in size
Technique(s) : FISH

More information
SPAIN

Cataluña
L'HOSPITALET DE LLOBREGAT

Accreditation Diagnosis of hereditary breast, colon and ovarian cancer syndromes (gene panel)
Reference Laboratory Genetics
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Bayern
MÜNCHEN

Accreditation Molecular diagnosis of cancers predisposition by TruSight Cancer panel (NGS panel)
Medizinisch Genetisches Zentrum München
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Baden-Württemberg
ULM

Accreditation Molecular diagnosis of cancers predisposition by TruSight Cancer panel (NGS panel)
Universitätsklinikum Ulm
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
FRANCE

OCCITANIE
TOULOUSE

Accreditation Diagnosis of predisposition to breast, ovarian and colon cancer (Panel)
IUCT Oncopole - CLCC Institut Claudius Regaud
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
FRANCE

GRAND-EST
VANDOEUVRE-LÈS-NANCY

Accreditation Diagnosis of predisposition to breast, ovarian and colon cancer (Panel)
CHU de Nancy - Hôpitaux de Brabois
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Bayern
WÜRZBURG

Accreditation Molecular diagnosis of cancers predisposition by TruSight Cancer panel (NGS panel)
Universität Würzburg - Biozentrum
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
NETHERLANDS

Utrecht
UTRECHT

Accreditation Molecular diagnosis of Familiar Breast and/or Ovarian Cancer (gene panel; ONC01v16.1)
UMC Utrecht - Universitair Medisch Centrum Utrecht
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
NETHERLANDS

Utrecht
UTRECHT

Accreditation Molecular diagnosis of Familiar Breast and/or Ovarian Cancer (gene panel incl CHEK2 gene; ONC02v16.1)
UMC Utrecht - Universitair Medisch Centrum Utrecht
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
ESTONIA

Tartu
TARTU

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (panel)
Asper Biogene
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SWITZERLAND

Suisse Romande
SION

Accreditation Diagnosis of hereditary cancer predisposition (panel)
Institut Central des Hôpitaux (ICH)
Purpose(s) : Post-natal diagnosis, Pre-symptomatic diagnosis, Somatic genetics, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Accreditation Diagnosis of predipositon to tumor (melanoma, pancreas, kidney, breast-ovary, colon, skin cancer) (Panel)
CLCC Institut Paoli Calmettes
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
NETHERLANDS

Gelderland
NIJMEGEN

Accreditation Molecular diagnosis of Hereditary Cancer (whole exome sequencing)
Radboudumc - Radboud universitair medisch centrum
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Whole Exome Sequencing (WES)

More information
SPAIN

Cataluña
L'HOSPITALET DE LLOBREGAT

Accreditation Diagnosis of hereditary breast cancer (PALB2 gene)
Reference Laboratory Genetics
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
FRANCE

ILE-DE-FRANCE
PARIS

Accreditation Diagnosis of predisposition to breast and ovarian cancer (Panel)
CHU Paris Centre - Hôpital Cochin, Site Cochin
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Bayern
BAD STEBEN

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, BRIP1, CHEK2, PALB2, RAD51C, RAD51D genes)
Institut für angewandte Humangenetik und Onkogenetik
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
GERMANY

Berlin
BERLIN

Accreditation Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2 genes)
IFLb Laboratoriumsmedizin Berlin GmbH
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
UNITED KINGDOM

Antrim and Newtownabbey
BELFAST

Accreditation Molecular diagnosis of Familial Breast / Ovarian Cancer by sequencing of the entire coding region of gene (s) / copy number analysis (BRCA1, BRCA2 1 genes)
Belfast City Hospital
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region

More information
GERMANY

Baden-Württemberg
TÜBINGEN

Accreditation Molecular diagnosis of predisposition to breast cancer (PALB2 gene)
CeGaT GmbH
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
FRANCE

BOURGOGNE-FRANCHE-COMTE
DIJON

Accreditation Diagnosis of predisposition to breast, ovarian and colon cancer (Panel)
CLCC Georges-François Leclerc
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Baden-Württemberg
TÜBINGEN

Accreditation Molecular analysis of somatic mutation in tumour tissue for therapeutic decisions (Somatic Tumor Panel, 710 genes)
CeGaT GmbH
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Cataluña
BARCELONA

Diagnosis of breast and ovarian cancer (panel)
Hospital de la Santa Creu i Sant Pau
Purpose(s) : Antenatal diagnosis, Post-natal diagnosis, Pre-symptomatic diagnosis, Risk assessment
Specialty(ies) : Molecular genetics, Cytogenetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis, Detection of microdeletions/microduplications
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Nordrhein-Westfalen
MÜNSTER

Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CDH1, RAD51C genes)
Institut für Humangenetik des Universitätsklinikums Münster
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Hamburg
HAMBURG

Molecular diagnosis of predisposition to breast and ovarian cancer (CHEK2, BRCA1, BRCA2, RAD51C genes)
Pränatalzentrum Hamburg und Humangenetik
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Bremen
BREMEN

Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
Praxis für Humangenetik
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Niedersachsen
OSNABRÜCK

Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, RAD51C genes)
Praxis Dres. Gencik
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Hessen
FRANKFURT AM MAIN

Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes: sequencing / MLPA)
bio.logis Zentrum für Humangenetik
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
GERMANY

Baden-Württemberg
ULM

Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, RAD51C genes)
MVZ Humangenetik Ulm
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Baden-Württemberg
STUTTGART

Molecular diagnosis of predisposition to breast and ovarian cancer (ATM, BRCA1, BRCA2, CDH1, CHEK2, NBN, PALB2, PTEN, RAD51C, RAD51D, TP53, XRCC2 genes)
Klinikum Stuttgart - Standort Olgahospital
Purpose(s) : Post-natal diagnosis, Pre-symptomatic diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
GERMANY

Sachsen
DRESDEN

Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, BRIP1, CHEK2, RAD51C, RAD51D, PALB2, PTEN)
Gemeinschaftspraxis für Humangenetik
Purpose(s) : Post-natal diagnosis, Pre-symptomatic diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
GERMANY

Nordrhein-Westfalen
AACHEN

Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
Praxis für Humangenetik Dr. Lemmens
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Hessen
WIESBADEN

Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes: sequencing)
Institut für Humangenetik Wiesbaden
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Nordrhein-Westfalen
MÜNSTER

Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, RAD51C genes)
Institut für Humangenetik des Universitätsklinikums Münster
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Sachsen
LEIPZIG

Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, RAD51C genes)
Institut für Humangenetik am Universitätsklinikum Leipzig
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
PORTUGAL

NORTE
PORTO

Molecular diagnosis of breast cancer (NGS panel for ATM, BRCA1, BRSA2, BRIP1, CDH1, CHEK2, ERCC4, MLH1, MSH2, MSH6, MUTYH, PALB2, PMS2, PTEN, RAD51C, RAD51D, STK11, TP53 genes: Sequencing of the entire coding region)
CGC Genetics / Centro de Genética Clínica
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Asturias
OVIEDO

Diagnosis of susceptibility to genetic gynecological tumor (BRCA1, BRCA2 genes)
IMOMA - Instituto de Medicina Oncológica y Molecular de Asturias
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
GERMANY

Baden-Württemberg
FREIBURG

Molecular diagnosis of predisposition to breast and ovarian cancer (BARD1, BRCA1, BRCA2, BRIP1, CHEK2, MRE11, NBN, PALB2, PTEN, RAD51C, RAD51D, TP53 genes)
Institut für Humangenetik am Universitätsklinikum Freiburg
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Mutation scanning/screening and sequence analysis of selected exons, Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES), Sanger sequencing

More information
SPAIN

Comunidad Valenciana
ALZIRA

Molecular diagnosis of susceptibility to hereditary breast cancer (BRCA1, BRCA2 genes)
Hospital Universitario de La Ribera
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics

More information
SPAIN

Madrid
MADRID

Diagnosis of hereditary breast cancera
Fundación Jiménez Díaz
Purpose(s) : Antenatal diagnosis, Pre-implantation diagnosis, Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Deletion / Duplication analysis
Technique(s) : MLPA based techniques

More information
GERMANY

Bayern
ERLANGEN

Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, RAD51C genes)
Humangenetisches Institut am Universitätsklinikum Erlangen
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
SPAIN

Comunidad Valenciana
ELCHE

Diagnosis of hereditary breast and ovarian cancer syndrome (gene panel)
Bioarray
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Sachsen
DRESDEN

Molecular diagnosis of cancers predisposition by TruSight Cancer panel (NGS panel)
Universitätsklinikum Carl Gustav Carus an der TU Dresden
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
FRANCE

OCCITANIE
MONTPELLIER

Diagnosis of predisposition to hereditary breast and ovarian cancer syndrome (Panel)
CHRU de Montpellier - Hôpital Arnaud de Villeneuve
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis, Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES), Sanger sequencing, MLPA based techniques

More information
SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

Diagnosis of genetic gynecological tumors and related disorders (panel, qCancer Gine)
qGenomics
Purpose(s) : Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

Diagnosis of BRCA-associated cancer (panel, qCancer BRCAs)
qGenomics
Purpose(s) : Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

Diagnosis of rare neoplastic diseases (panel, qCancer Risk)
qGenomics
Purpose(s) : Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Madrid
MADRID

Diagnosis of hereditary cancer (panel)
Fundación Jiménez Díaz
Purpose(s) : Antenatal diagnosis, Pre-implantation diagnosis, Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

País Vasco
SAN SEBASTIÁN

Diagnosis of hereditary breast cancer (BRCA1, BRCA2 genes)
DNA Data
Purpose(s) : Pre-symptomatic diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Deletion / Duplication analysis
Technique(s) : MLPA based techniques

More information
FRANCE

AUVERGNE-RHONE-ALPES
LYON

Diagnosis of predisposition to breast and/or ovarian cancer (Panel)
Laboratoire Alpigene
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons
Technique(s) : NGS sequencing (except WES)

More information
CYPRUS

Cyprus
NICOSIA

Mutation screening for familial breast cancer (BRCA1 17q21.3)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons

More information
GERMANY

Hessen
FRANKFURT AM MAIN

Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
Praxis Dr. med. Ulrike Beudt
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Nordrhein-Westfalen
BONN

Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 and BRCA2 genes)
Institut für Klinische Genetik Bonn
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
GERMANY

Berlin
BERLIN

Molecular diagnosis of cancer (NGS screening panel, 402 genes)
ATG GenMed GmbH
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : NGS sequencing (except WES)

More information
GERMANY

Berlin
BERLIN

'Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1 gene: seq/MLPA; BRCA2, BRIP1, CDH1, CHEK2, NBN, RAD50, RAD51C, PALB2, PTEN genes: sequencing)'
ATG GenMed GmbH
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : Sanger sequencing, MLPA based techniques

More information
GERMANY

Hamburg
HAMBURG

Molecular diagnosis of predisposition to breast and ovarian cancer (BRCA1, BRCA2, CHEK2, RAD51C genes)
UKE - Universitätsklinikum Hamburg-Eppendorf
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region
Technique(s) : Sanger sequencing

More information
CYPRUS

Cyprus
NICOSIA

Mutation Screening for Breast and Ovarian Cancer (PTEN 10q23.31)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons

More information
CYPRUS

Cyprus
NICOSIA

Analysis of known mutation for Breast and Ovarian Cancer (PTEN 10q23.31)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis

More information
CYPRUS

Cyprus
NICOSIA

Mutation screening for familial breast cancer (BRCA2 13q13.1)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons

More information
CYPRUS

Cyprus
NICOSIA

Analysis of known mutation of familial breast cancer (BRCA2 13q13.1)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis

More information
CYPRUS

Cyprus
NICOSIA

Analysis of known mutation of familial breast cancer (BRCA1 13q21.3)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis

More information
CYPRUS

Cyprus
NICOSIA

Analysis of known mutations for Breast and Ovarian Cancer (STK11 19p13.3)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis

More information
CYPRUS

Cyprus
NICOSIA

Mutation screening for Breast and Ovarian Cancer (STK11 19p13.3)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons

More information
CYPRUS

Cyprus
NICOSIA

Analysis of known mutations for Breast and Ovarian Cancer (CHEK2 22q12.1)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis

More information
CYPRUS

Cyprus
NICOSIA

Analysis of known mutations for Breast and Ovarian Cancer (ATM 11q22.3)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis

More information
CYPRUS

Cyprus
NICOSIA

Mutation Screening for Breast and Ovarian Cancer (ATM 11q22.3)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons

More information
CYPRUS

Cyprus
NICOSIA

Mutation Screening for Breast and Ovarian Cancer (PALB2 16p12.2)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons

More information
CYPRUS

Cyprus
NICOSIA

Analysis of known mutations for Breast and Ovarian Cancer (PALB2 16p12.2)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis

More information
CYPRUS

Cyprus
NICOSIA

Analysis of known mutations for Breast and Ovarian Cancer (BRIP1 17q23.2)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis

More information
CYPRUS

Cyprus
NICOSIA

Mutation screening for Breast and Ovarian Cancer (BRIP1 17q23.2)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons

More information
CYPRUS

Cyprus
NICOSIA

Mutation screening for Breast and Ovarian Cancer (BRAF 7q34)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Mutation scanning/screening and sequence analysis of selected exons

More information
CYPRUS

Cyprus
NICOSIA

Analysis of known mutations for Breast and Ovarian Cancer (BRAF 7q34)
The Cyprus Institute of Neurology and Genetics
Purpose(s) : Post-natal diagnosis, Somatic genetics
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis

More information
SPAIN

La Rioja
LOGROÑO

Diagnosis of breast and ovarian cancer (panel)
Hospital San Pedro
Purpose(s) : Post-natal diagnosis
Specialty(ies) : Molecular genetics
Objective(s) : Sequence analysis: entire coding region, Deletion / Duplication analysis
Technique(s) : NGS sequencing (except WES)

More information
SPAIN

Andalucía
GRANADA

Diagnosis of hereditary cancer (panel)
Hospital Universitario San Cecilio
Purpose(s) : Post-natal diagnosis, Risk assessment
Specialty(ies) : Molecular genetics
Objective(s) : Targeted mutation analysis
Technique(s) : NGS sequencing (except WES)

More information